Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Affymax Inc AFFY

Healthcare Biotechnology
Affymax, Inc. is a biopharmaceutical company. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The Company has a collaboration to develop and commercialize peginesatide with... see more

Recent & Breaking News (GREY:AFFY)

Arrayit (ARYC) Featured on PBS NOVA Series

ACCESS Newswire April 29, 2013

Glancy Binkow & Goldberg Encourages Investors to Inquire About a Lead Plaintiff Position in the Class Action Lawsuit Against Affymax, Inc. -- AFFY

Globe Newswire April 28, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and Upcoming Deadline -- AFFY

Globe Newswire April 26, 2013

AFFYMAX 96 HOUR SHAREHOLDER ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Large Financial Interests of Important Deadline in Lawsuit Against Affymax, Inc.

Business Wire April 25, 2013

Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline in the Class Action Lawsuit against Affymax, Inc.

Business Wire April 23, 2013

UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and the Deadline of April 29, 2013 to Seek a Lead Plaintiff Position

PR Newswire April 23, 2013

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and the Deadline of April 29, 2013 to Seek a Lead Plaintiff Position

Business Wire April 19, 2013

Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Affymax, Inc.

Business Wire April 12, 2013

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and the Deadline of April 29, 2013 to Seek a Lead Plaintiff Position

Business Wire April 10, 2013

Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Affymax, Inc.

Business Wire April 6, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and Upcoming Deadline -- AFFY

Globe Newswire April 5, 2013

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and the Deadline of April 29, 2013 to Seek a Lead Plaintiff Position

Marketwired April 5, 2013

Squitieri & Fearon, LLP Pursues Claims Against Affymax, Inc. -- AFFY

Globe Newswire April 4, 2013

Harwood Feffer LLP Announces Investigation of Affymax, Inc.

PR Newswire April 3, 2013

Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Affymax, Inc.

Business Wire April 2, 2013

Free Research Reports on AFFY, BZH, MTG and Z Issued by the Bedford Report

Marketwired April 1, 2013

Morning Research on Amgen, Affymax, Vertex Pharma, Questcor Pharma, and Repros Therapeutics

PR Newswire April 1, 2013

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Affymax, Inc.

Business Wire March 25, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and Upcoming Deadline - AFFY

Globe Newswire March 22, 2013

Free Research Reports on ACAD, ANAC, AFFY and DNN Issued by the Bedford Report

Marketwired March 22, 2013